This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Functional Validation of the CD2AP Susceptibility Network in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Genome wide analysis of LXR binding – metabolic and epigenetic regulation in AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMERS DISEASE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Characterization of Alzheimers Mutations in ADAM10. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Genome-wide Profiling of Brain DNA Hydroxymethylome in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Identification and characterization of AD risk networks using multi-dimensional omics data Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
RNA splicing dysfunction in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Role of the TOMM40 poly-T variant in the pathogenesis of Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Pleiotropic and Interaction Effects on Alzheimers disease Risk and Progression Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
Characterizing the glymphatic peri-vascular connectome and its disruption in AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016
